Kathmere Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3M Buy
21,586
+1,661
+8% +$255K 0.2% 90
2025
Q4
$2.75M Sell
19,925
-939
-5% -$123K 0.18% 91
2025
Q3
$2.68M Buy
20,864
+3,501
+20% +$427K 0.19% 94
2025
Q2
$2.1M Sell
17,363
-1,379
-7% -$155K 0.16% 99
2025
Q1
$2.09M Buy
18,742
+5,788
+45% +$616K 0.18% 86
2024
Q4
$1.26M Sell
12,954
-4,816
-27% -$514K 0.11% 117
2024
Q3
$2.04M Buy
17,770
+4,056
+30% +$460K 0.19% 81
2024
Q2
$1.46M Buy
13,714
+1,235
+10% +$124K 0.15% 83
2024
Q1
$1.21M Buy
12,479
+1,311
+12% +$134K 0.14% 86
2023
Q4
$1.13M Sell
11,168
-83
-0.7% -$8.01K 0.15% 80
2023
Q3
$1.15M Buy
11,251
+986
+10% +$100K 0.17% 75
2023
Q2
$1.04M Buy
10,265
+755
+8% +$75.5K 0.16% 70
2023
Q1
$875K Buy
9,510
+259
+3% +$22.6K 0.14% 80
2022
Q4
$839K Buy
+9,251
New +$779K 0.15% 78
2022
Q3
Sell
-4,182
Closed -$354K 189
2022
Q2
$354K Buy
4,182
+938
+29% +$82.3K 0.07% 103
2022
Q1
$285K Buy
+3,244
New +$281K 0.05% 136

Other funds holding NVS